<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0053">
 <label>53</label>
 <mixed-citation publication-type="journal" id="CIT0053-gen-2">(a) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Nordberg</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ballard</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bullock</surname>
    <given-names>R</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease</article-title>. 
  <source>Prim Care Companion CNS Disord</source>
  <year>2013</year>;
  <volume>15</volume>:
  <fpage>PCC.12r01412</fpage>.
  <pub-id pub-id-type="pmid">23930233</pub-id>
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0053-gen-3">(b) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Greig</surname>
    <given-names>NH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lahiri</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sambamurti</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Butyrylcholinesterase: an important new target in Alzheimer’s disease therapy</article-title>. 
  <source>Int Psychogeriatr</source>
  <year>2002</year>;
  <volume>14</volume>:
  <fpage>77</fpage>–
  <lpage>91</lpage>.
  <pub-id pub-id-type="pmid">12636181</pub-id>
 </mixed-citation>
</ref>
